Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OMKARCHEM.NS Stock Summary
Top 10 Correlated ETFs
OMKARCHEM.NS
In the News
OMKARCHEM.NS Financial details
Company Rating
Buy
Market Cap
173.88M
Income
-164.94M
Revenue
193.58M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
59
Optionable
No
Shortable
Yes
Earnings
19 Dec 2023
P/E
-1.36
Forward P/E
-
PEG
0.01
P/S
0.75
P/B
-0.1
P/C
-
P/FCF
19.26
Quick Ratio
0.05
Current Ratio
0.15
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-8
EPS next Y
-
EPS next Q
-
EPS this Y
-725.51%
EPS next Y
-
EPS next 5Y
-639.71%
EPS last 5Y
-34.42%
Revenue last 5Y
-34.57%
Revenue Q/Q
-25.96%
EPS Q/Q
-29.21%
-
-
-
-
SMA20
12.5%
SMA50
12.5%
SMA100
-18.18%
Inst Own
-
Inst Trans
-
ROA
-17%
ROE
8%
ROC
-
Gross Margin
27%
Oper. Margin
-
Profit Margin
-55%
Payout
-
Shs Outstand
20.58M
Shs Float
12.33M
-
-
-
-
Target Price
-
52W Range
6.8-18.25
52W High
-53.61%
52W Low
+39.17%
RSI
44
Rel Volume
0.51
Avg Volume
22.19K
Volume
11.24K
Perf Week
-8.24%
Perf Month
-1.18%
Perf Quarter
8.44%
Perf Half Y
5.03%
-
-
-
-
Beta
-0.065
-
-
Volatility
0.14%, 0.49%
Prev Close
-1.18%
Price
8.35
Change
1.83%
OMKARCHEM.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 93.1 | 20.73 | 27.64 | 21.96 | 11.18 | |
Net income per share | -50.52 | -8.2 | -7.11 | 0.98 | -6.13 | |
Operating cash flow per share | 12.61 | 0.67 | 1.95 | -7.99 | 0.43 | |
Free cash flow per share | -13.85 | 0.56 | 1.94 | -8 | 0.43 | |
Cash per share | 5.51 | 0.21 | 0.34 | 0.43 | 5.03 | |
Book value per share | -60.79 | -71.96 | -78.96 | -77.06 | -83.18 | |
Tangible book value per share | -60.86 | -72.02 | -79 | -77.06 | -83.18 | |
Share holders equity per share | -60.79 | -71.96 | -78.96 | -77.06 | -83.18 | |
Interest debt per share | 124.78 | 118.59 | 115.77 | 113.69 | 112.62 | |
Market cap | 706.85M | 341.59M | 50.42M | 239.37M | 607.64M | |
Enterprise value | 3.02B | 2.64B | 2.38B | 2.52B | 2.86B | |
P/E ratio | -0.68 | -2.02 | -0.34 | 11.89 | -4.82 | |
Price to sales ratio | 0.37 | 0.8 | 0.09 | 0.53 | 2.64 | |
POCF ratio | 2.72 | 24.78 | 1.26 | -1.46 | 68.11 | |
PFCF ratio | -2.48 | 29.82 | 1.27 | -1.46 | 68.11 | |
P/B Ratio | -0.57 | -0.23 | -0.03 | -0.15 | -0.36 | |
PTB ratio | -0.57 | -0.23 | -0.03 | -0.15 | -0.36 | |
EV to sales | 1.58 | 6.18 | 4.19 | 5.58 | 12.45 | |
Enterprise value over EBITDA | -7.04 | 430.34 | 2.17K | 30.85 | -60.28 | |
EV to operating cash flow | 11.64 | 191.24 | 59.27 | -15.35 | 320.65 | |
EV to free cash flow | -10.6 | 230.1 | 59.75 | -15.33 | 320.65 | |
Earnings yield | -1.47 | -0.49 | -2.9 | 0.08 | -0.21 | |
Free cash flow yield | -0.4 | 0.03 | 0.79 | -0.69 | 0.01 | |
Debt to equity | -1.86 | -1.55 | -1.44 | -1.44 | -1.32 | |
Debt to assets | 1.71 | 2.14 | 2.4 | 2.64 | 3.12 | |
Net debt to EBITDA | -5.39 | 374.57 | 2.12K | 27.91 | -47.47 | |
Current ratio | 0.19 | 0.12 | 0.16 | 0.26 | 0.15 | |
Interest coverage | -2.14 | 0 | 0 | 0 | 0 | |
Income quality | -0.21 | -0.12 | -0.36 | -5.21 | -0.07 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.04 | 0.06 | 0.04 | 0.03 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -2.1 | -0.17 | -0.01 | 0 | 0 | |
Capex to revenue | -0.28 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | -6.67 | -0.03 | 0 | -0.01 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 262.87 | 115.23 | 112.4 | 41.22 | 107.11 | |
ROIC | -0.39 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -0.76 | -0.16 | -0.15 | 0.02 | -0.17 | |
Graham Net | -120.38 | -123.14 | -115.51 | -101.98 | -112.05 | |
Working capital | -1.49B | -1.59B | -1.55B | -1.31B | -2.07B | |
Tangible asset value | -1.25B | -1.48B | -1.63B | -1.58B | -1.71B | |
Net current asset value | -2.26B | -2.34B | -2.3B | -1.98B | -2.08B | |
Invested capital | -1.86 | -1.55 | -1.44 | -1.44 | -1.32 | |
Average receivables | 772.96M | 0 | 129.79M | 353.96M | 234.48M | |
Average payables | 539.89M | 191.84M | 190.68M | 141.12M | 100.49M | |
Average inventory | 387.25M | 36.12M | 33.65M | 25.77M | 15.68M | |
Days sales outstanding | 0 | 0 | 166.57 | 362.65 | 32.74 | |
Days payables outstanding | 30.01 | 212.46 | 131.53 | 112.49 | 215.38 | |
Days of inventory on hand | 7.13 | 30.55 | 28.04 | 14.5 | 39.69 | |
Receivables turnover | 0 | 0 | 2.19 | 1.01 | 11.15 | |
Payables turnover | 12.16 | 1.72 | 2.77 | 3.24 | 1.69 | |
Inventory turnover | 51.21 | 11.95 | 13.02 | 25.17 | 9.2 | |
ROE | 0.83 | 0.11 | 0.09 | -0.01 | 0.07 | |
Capex per share | -26.46 | -0.11 | -0.02 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q1
Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.58 | 2.06 | 3.07 | 2.44 | 1.82 | |
Net income per share | -1.11 | -1.73 | -0.89 | -3.15 | -2.23 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 5.02 | 0 | 5.01 | 0 | |
Book value per share | 0 | -79.79 | 0 | -82.78 | 0 | |
Tangible book value per share | 0 | -79.79 | 0 | -82.78 | 0 | |
Share holders equity per share | 0 | -79.79 | 0 | -82.78 | 0 | |
Interest debt per share | 0.7 | 106.62 | 0.76 | 109.9 | 0.82 | |
Market cap | 186.23M | 344.41M | 651.92M | 610.59M | 446.56M | |
Enterprise value | 186.23M | 2.52B | 651.92M | 2.86B | 446.56M | |
P/E ratio | -2.04 | -2.42 | -8.86 | -2.35 | -2.43 | |
Price to sales ratio | 2.53 | 8.14 | 10.28 | 12.1 | 11.95 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | -0.21 | 0 | -0.36 | 0 | |
PTB ratio | 0 | -0.21 | 0 | -0.36 | 0 | |
EV to sales | 2.53 | 59.56 | 10.28 | 56.74 | 11.95 | |
Enterprise value over EBITDA | -49.2 | -157.14 | 479.7 | -98.76 | -54.08 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.12 | -0.1 | -0.03 | -0.11 | -0.1 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | -1.33 | 0 | -1.32 | 0 | |
Debt to assets | 0 | 2.85 | 0 | 3.12 | 0 | |
Net debt to EBITDA | 0 | -135.67 | 0 | -77.7 | 0 | |
Current ratio | 0 | 0.16 | 0 | 0.15 | 0 | |
Interest coverage | -0.6 | -1.88 | -0.17 | -2.12 | -0.72 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 55.73 | 0 | 76.58 | 0 | |
ROIC | 0 | -0.06 | 0 | -0.08 | 0 | |
Return on tangible assets | 0 | -0.05 | 0 | -0.09 | 0 | |
Graham Net | 0 | -109.94 | 0 | -111.51 | 0 | |
Working capital | 2.63K | -2.02B | 3.19K | -2.07B | 3.33K | |
Tangible asset value | 0 | -1.64B | 0 | -1.71B | 0 | |
Net current asset value | 2.63K | -2.03B | 3.19K | -2.08B | 3.33K | |
Invested capital | 0 | -1.33 | 0 | -1.32 | 0 | |
Average receivables | 224.17M | 19.2M | 19.2M | 10.31M | 10.31M | |
Average payables | 51.22M | 70.63M | 70.63M | 49.27M | 49.27M | |
Average inventory | 6.6M | 11.39M | 11.39M | 9.08M | 9.08M | |
Days sales outstanding | 0 | 81.67 | 0 | 36.76 | 0 | |
Days payables outstanding | 0 | 369.27 | 0 | 216.04 | 0 | |
Days of inventory on hand | 0 | 59.56 | 0 | 39.81 | 0 | |
Receivables turnover | 0 | 1.1 | 0 | 2.45 | 0 | |
Payables turnover | 0 | 0.24 | 0 | 0.42 | 0 | |
Inventory turnover | 0 | 1.51 | 0 | 2.26 | 0 | |
ROE | 0 | 0.02 | 0 | 0.04 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
OMKARCHEM.NS Frequently Asked Questions
What is Omkar Speciality Chemicals Limited stock symbol ?
Omkar Speciality Chemicals Limited is a IN stock and trading under the symbol OMKARCHEM.NS
What is Omkar Speciality Chemicals Limited stock quote today ?
Omkar Speciality Chemicals Limited stock price is $8.35 today.
Is Omkar Speciality Chemicals Limited stock public?
Yes, Omkar Speciality Chemicals Limited is a publicly traded company.